Selected research
Industry Research
CRO Services for BioPharma Industry Research Report 2026
Market perspective
The global CRO Services for BioPharma market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the CRO Services for BioPharma market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the CRO Services for BioPharma market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the CRO Services for BioPharma market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of CRO Services for BioPharma include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health and Charles River Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global CRO Services for BioPharma market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to CRO Services for BioPharma.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CRO Services for BioPharma Market by Company
PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON
CRO Services for BioPharma Segment by Type
Preclinical CRO
Clinical Trial CRO
CRO Services for BioPharma Segment by Application
Commercial
Scientific Research
Other
CRO Services for BioPharma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO Services for BioPharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRO Services for BioPharma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO Services for BioPharma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of CRO Services for BioPharma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preclinical CRO
- Clinical Trial CRO
Applications
- Commercial
- Scientific Research
- Other
Companies covered
- PPD (Thermo Fisher)
- Space Peptides
- Aurigene Pharmaceutical Services
- IQVIA
- Labcorp Drug Development
- Parexel
- ICON plc
- Syneos Health
- Charles River Laboratories
- Medpace
- SGS SA
- KCR CRO
- TFS HealthScience
- Caidya
- Worldwide Clinical Trials
- CTI
- Advanced Clinical
- WuXi AppTec
- Pharmaron Inc.
- Hangzhou Tigermed Consulting
- JOINN Laboratories
- MEDICILON
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 CRO Services for BioPharma by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Preclinical CRO
- 2.2.3 Clinical Trial CRO
- 2.3 CRO Services for BioPharma by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial
- 2.3.3 Scientific Research
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 CRO Services for BioPharma Breakdown Data by Type
- 3.1 Global CRO Services for BioPharma Historic Market Size by Type (2021-2026)
- 3.2 Global CRO Services for BioPharma Forecasted Market Size by Type (2027-2032)
4 CRO Services for BioPharma Breakdown Data by Application
- 4.1 Global CRO Services for BioPharma Historic Market Size by Application (2021-2026)
- 4.2 Global CRO Services for BioPharma Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global CRO Services for BioPharma Market Perspective (2021-2032)
- 5.2 Global CRO Services for BioPharma Growth Trends by Region
- 5.2.1 Global CRO Services for BioPharma Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 CRO Services for BioPharma Historic Market Size by Region (2021-2026)
- 5.2.3 CRO Services for BioPharma Forecasted Market Size by Region (2027-2032)
- 5.3 CRO Services for BioPharma Market Dynamics
- 5.3.1 CRO Services for BioPharma Industry Trends
- 5.3.2 CRO Services for BioPharma Market Drivers
- 5.3.3 CRO Services for BioPharma Market Challenges
- 5.3.4 CRO Services for BioPharma Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top CRO Services for BioPharma Players by Revenue
- 6.1.1 Global Top CRO Services for BioPharma Players by Revenue (2021-2026)
- 6.1.2 Global CRO Services for BioPharma Revenue Market Share by Players (2021-2026)
- 6.2 Global CRO Services for BioPharma Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of CRO Services for BioPharma Head Office and Area Served
- 6.4 Global CRO Services for BioPharma Players, Product Type & Application
- 6.5 Global CRO Services for BioPharma Manufacturers Established Date
- 6.6 Global CRO Services for BioPharma Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America CRO Services for BioPharma Market Size (2021-2032)
- 7.2 North America CRO Services for BioPharma Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America CRO Services for BioPharma Market Size by Country (2021-2026)
- 7.4 North America CRO Services for BioPharma Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe CRO Services for BioPharma Market Size (2021-2032)
- 8.2 Europe CRO Services for BioPharma Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe CRO Services for BioPharma Market Size by Country (2021-2026)
- 8.4 Europe CRO Services for BioPharma Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific CRO Services for BioPharma Market Size (2021-2032)
- 9.2 Asia-Pacific CRO Services for BioPharma Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific CRO Services for BioPharma Market Size by Country (2021-2026)
- 9.4 Asia-Pacific CRO Services for BioPharma Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America CRO Services for BioPharma Market Size (2021-2032)
- 10.2 South America CRO Services for BioPharma Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America CRO Services for BioPharma Market Size by Country (2021-2026)
- 10.4 South America CRO Services for BioPharma Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa CRO Services for BioPharma Market Size (2021-2032)
- 11.2 Middle East & Africa CRO Services for BioPharma Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa CRO Services for BioPharma Market Size by Country (2021-2026)
- 11.4 Middle East & Africa CRO Services for BioPharma Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 PPD (Thermo Fisher)
- 12.1.1 PPD (Thermo Fisher) Company Information
- 12.1.2 PPD (Thermo Fisher) Business Overview
- 12.1.3 PPD (Thermo Fisher) Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.1.4 PPD (Thermo Fisher) CRO Services for BioPharma Product Portfolio
- 12.1.5 PPD (Thermo Fisher) Recent Developments
- 12.2 Space Peptides
- 12.2.1 Space Peptides Company Information
- 12.2.2 Space Peptides Business Overview
- 12.2.3 Space Peptides Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.2.4 Space Peptides CRO Services for BioPharma Product Portfolio
- 12.2.5 Space Peptides Recent Developments
- 12.3 Aurigene Pharmaceutical Services
- 12.3.1 Aurigene Pharmaceutical Services Company Information
- 12.3.2 Aurigene Pharmaceutical Services Business Overview
- 12.3.3 Aurigene Pharmaceutical Services Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.3.4 Aurigene Pharmaceutical Services CRO Services for BioPharma Product Portfolio
- 12.3.5 Aurigene Pharmaceutical Services Recent Developments
- 12.4 IQVIA
- 12.4.1 IQVIA Company Information
- 12.4.2 IQVIA Business Overview
- 12.4.3 IQVIA Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.4.4 IQVIA CRO Services for BioPharma Product Portfolio
- 12.4.5 IQVIA Recent Developments
- 12.5 Labcorp Drug Development
- 12.5.1 Labcorp Drug Development Company Information
- 12.5.2 Labcorp Drug Development Business Overview
- 12.5.3 Labcorp Drug Development Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.5.4 Labcorp Drug Development CRO Services for BioPharma Product Portfolio
- 12.5.5 Labcorp Drug Development Recent Developments
- 12.6 Parexel
- 12.6.1 Parexel Company Information
- 12.6.2 Parexel Business Overview
- 12.6.3 Parexel Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.6.4 Parexel CRO Services for BioPharma Product Portfolio
- 12.6.5 Parexel Recent Developments
- 12.7 ICON plc
- 12.7.1 ICON plc Company Information
- 12.7.2 ICON plc Business Overview
- 12.7.3 ICON plc Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.7.4 ICON plc CRO Services for BioPharma Product Portfolio
- 12.7.5 ICON plc Recent Developments
- 12.8 Syneos Health
- 12.8.1 Syneos Health Company Information
- 12.8.2 Syneos Health Business Overview
- 12.8.3 Syneos Health Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.8.4 Syneos Health CRO Services for BioPharma Product Portfolio
- 12.8.5 Syneos Health Recent Developments
- 12.9 Charles River Laboratories
- 12.9.1 Charles River Laboratories Company Information
- 12.9.2 Charles River Laboratories Business Overview
- 12.9.3 Charles River Laboratories Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.9.4 Charles River Laboratories CRO Services for BioPharma Product Portfolio
- 12.9.5 Charles River Laboratories Recent Developments
- 12.10 Medpace
- 12.10.1 Medpace Company Information
- 12.10.2 Medpace Business Overview
- 12.10.3 Medpace Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.10.4 Medpace CRO Services for BioPharma Product Portfolio
- 12.10.5 Medpace Recent Developments
- 12.11 SGS SA
- 12.11.1 SGS SA Company Information
- 12.11.2 SGS SA Business Overview
- 12.11.3 SGS SA Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.11.4 SGS SA CRO Services for BioPharma Product Portfolio
- 12.11.5 SGS SA Recent Developments
- 12.12 KCR CRO
- 12.12.1 KCR CRO Company Information
- 12.12.2 KCR CRO Business Overview
- 12.12.3 KCR CRO Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.12.4 KCR CRO CRO Services for BioPharma Product Portfolio
- 12.12.5 KCR CRO Recent Developments
- 12.13 TFS HealthScience
- 12.13.1 TFS HealthScience Company Information
- 12.13.2 TFS HealthScience Business Overview
- 12.13.3 TFS HealthScience Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.13.4 TFS HealthScience CRO Services for BioPharma Product Portfolio
- 12.13.5 TFS HealthScience Recent Developments
- 12.14 Caidya
- 12.14.1 Caidya Company Information
- 12.14.2 Caidya Business Overview
- 12.14.3 Caidya Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.14.4 Caidya CRO Services for BioPharma Product Portfolio
- 12.14.5 Caidya Recent Developments
- 12.15 Worldwide Clinical Trials
- 12.15.1 Worldwide Clinical Trials Company Information
- 12.15.2 Worldwide Clinical Trials Business Overview
- 12.15.3 Worldwide Clinical Trials Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.15.4 Worldwide Clinical Trials CRO Services for BioPharma Product Portfolio
- 12.15.5 Worldwide Clinical Trials Recent Developments
- 12.16 CTI
- 12.16.1 CTI Company Information
- 12.16.2 CTI Business Overview
- 12.16.3 CTI Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.16.4 CTI CRO Services for BioPharma Product Portfolio
- 12.16.5 CTI Recent Developments
- 12.17 Advanced Clinical
- 12.17.1 Advanced Clinical Company Information
- 12.17.2 Advanced Clinical Business Overview
- 12.17.3 Advanced Clinical Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.17.4 Advanced Clinical CRO Services for BioPharma Product Portfolio
- 12.17.5 Advanced Clinical Recent Developments
- 12.18 WuXi AppTec
- 12.18.1 WuXi AppTec Company Information
- 12.18.2 WuXi AppTec Business Overview
- 12.18.3 WuXi AppTec Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.18.4 WuXi AppTec CRO Services for BioPharma Product Portfolio
- 12.18.5 WuXi AppTec Recent Developments
- 12.19 Pharmaron Inc.
- 12.19.1 Pharmaron Inc. Company Information
- 12.19.2 Pharmaron Inc. Business Overview
- 12.19.3 Pharmaron Inc. Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.19.4 Pharmaron Inc. CRO Services for BioPharma Product Portfolio
- 12.19.5 Pharmaron Inc. Recent Developments
- 12.20 Hangzhou Tigermed Consulting
- 12.20.1 Hangzhou Tigermed Consulting Company Information
- 12.20.2 Hangzhou Tigermed Consulting Business Overview
- 12.20.3 Hangzhou Tigermed Consulting Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.20.4 Hangzhou Tigermed Consulting CRO Services for BioPharma Product Portfolio
- 12.20.5 Hangzhou Tigermed Consulting Recent Developments
- 12.21 JOINN Laboratories
- 12.21.1 JOINN Laboratories Company Information
- 12.21.2 JOINN Laboratories Business Overview
- 12.21.3 JOINN Laboratories Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.21.4 JOINN Laboratories CRO Services for BioPharma Product Portfolio
- 12.21.5 JOINN Laboratories Recent Developments
- 12.22 MEDICILON
- 12.22.1 MEDICILON Company Information
- 12.22.2 MEDICILON Business Overview
- 12.22.3 MEDICILON Revenue in CRO Services for BioPharma Business (2021-2026)
- 12.22.4 MEDICILON CRO Services for BioPharma Product Portfolio
- 12.22.5 MEDICILON Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst